SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly)
PFE 25.51-0.8%11:25 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Anthony Wong who wrote (933)10/16/1998 11:35:00 AM
From: Anthony Wong  Read Replies (1) of 1722
 
Merck Reaffirms 1998 Earnings Estimates at $4.27 to $4.34-Share

Bloomberg News
October 16, 1998, 10:56 a.m. ET

Merck Reaffirms 1998 Earnings Estimates at $4.27 to $4.34-Share

Whitehouse Station, New Jersey, Oct. 16 (Bloomberg) -- Merck
& Co., the world's largest drugmaker, told analysts it's
comfortable with estimates that put its 1998 profit at $4.27 to
$4.34 a share, reaffirming the range it indicated in July.

Merck fell 15/16 to 132 5/16 in midmorning trading amid
concerns that its sales are not growing as quickly as they seem
to be, analysts said. The Whitehouse Station, New Jersey-based
company confirmed that it gave analysts the estimate range.

Merck today said third-quarter net income rose to $1.37
billion, or $1.12 a share, from $1.20 billion, or 97 cents, in
the year-earlier period. The results beat the $1.11-a-share
average estimate of analysts polled by First Call Corp.

Sales rose 15 percent to $6.84 billion from $5.93 billion.
The recent quarter may include some items that Merck will not
have in the future, analysts said.

--Kerry Dooley in the Princeton newsroom (609) 279-4016/esk
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext